Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for primary hyperparathyroidism in MEN1 mutation carriers
2010-018861-53Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cinacalcet in primary hyperparathyroidism (PHPT), sponsored by Leiden University Medical Center. Primary endpoint: Normalisation of serum calcium and parathyroid hormone. Started Feb 2010; status: active.
02
Drugs
cinacalcet
03
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on 2010-018861-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018861-53.